欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FI/H/1241/002
药品名称Candesartan/Indapamidi Krka 16 mg / 2,5 mg
活性成分
    • candesartancilexetil 16.0 mg
    • Indapamide 2.5 mg
剂型Tablet
上市许可持有人KRKA tovarna zdravil d.d. Novo mesto Šmarješka Cesta 6, Novo Mesto Jugovzhodna Slovenija, 8501 Slovenia
参考成员国 - 产品名称Finland (FI)
互认成员国 - 产品名称
    • Spain (ES)
    • Portugal (PT)
    • Poland (PL)
      Kanpiduo
    • Latvia (LV)
    • Lithuania (LT)
      Kanpiduo 16 mg/2,5 mg tabletės
    • Estonia (EE)
    • Hungary (HU)
    • Cyprus (CY)
      Candexin 16 mg/2,5 mg δισκία
    • Romania (RO)
      Kanpiduo 16 mg/2,5 mg comprimate
    • Slovakia (SK)
    • Germany (DE)
      Candexin 16 mg/2,5 mg Tabletten
    • Slovenia (SI)
    • Austria (AT)
许可日期2024/09/11
最近更新日期2024/09/11
药物ATC编码
    • C09DA06 candesartan and diuretics
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase